{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:17:02Z","timestamp":1790806622616,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To determine the impact of advanced hybrid closed - loop (AHCL) insulin delivery on quality of life, metabolic control and time in range (TIR) in youth with type 1 diabetes mellitus (T1DM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty-four children and adolescents with T1DM (14 female) aged of 10 to 18 years participated in the study. Mixed methods study design was implemented. Quantitative part of the study was conducted as a longitudinal crossover study with data collection before and at the end of AHCL use. Qualitative data were obtained with modeled interviews of four focus groups before and the end of the period. Clinical data were collected from the electronic medical records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The use of AHCL significantly improved the quality of life in terms of decreased fear of hypoglycemia (p&amp;lt;0.001), decrease in diabetes-related emotional distress (p&amp;lt;0.001), and increased wellbeing (p=0.003). The mean A1C decreased from 8.55 \u00b1 1.34% (69.9 \u00b1 12.3 mmol\/mol) to 7.73 \u00b1 0.42 (61.1 \u00b1 2.2 mmol\/mol) (p=0.002) at the end of the study. Mean TIR was 68.22% (\u00b1 13.89) before and 78.26 (\u00b1 6.29) % (p&amp;lt;0.001) at the end of the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of advanced hybrid closed loop significantly improved the quality of life and metabolic control in children and adolescents with T1DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.967725","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T10:26:18Z","timestamp":1660904778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery"],"prefix":"10.3389","volume":"13","author":[{"given":"Ana","family":"Gianini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Suklan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigita","family":"Skela-Savi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Klemencic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemen","family":"Dovc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Bratina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4763-3","article-title":"Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989\u20132013: A multicentre prospective registration study","volume":"62","author":"Patterson","year":"2019","journal-title":"Diabetologia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc22-s007","article-title":"Diabetes technology: Standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11892-019-1177-7","article-title":"Advanced technology in the management of diabetes: Which comes first-continuous glucose monitor or insulin pump","volume":"19","author":"Martin","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31142-0","article-title":"Advances in technology for management of type 1 diabetes","volume":"394","author":"Beck","year":"2019","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2337\/dc19-0895","article-title":"Faster compared with standard insulin aspart during day-and-Night full closed-loop insulin therapy in type 1 diabetes: A double-blind randomized crossover trial","volume":"43","author":"Dovc","year":"2020","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1932296815604439","article-title":"Factors associated with glycemic control during free-living overnight closed-loop insulin delivery in children and adults with type 1 diabetes","volume":"9","author":"Tauschmann","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2016.12.018","article-title":"The relationships among fear of hypoglycaemia, diabetes-related quality of life and psychological well-being in Norwegian adults with type 1 diabetes","volume":"124","author":"Strandberg","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61998-X","article-title":"Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial","volume":"375","author":"Hovorka","year":"2010","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11708","article-title":"Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes","volume":"316","author":"Bergenstal","year":"2016","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"18","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0264","article-title":"Safety evaluation of the MiniMed 670G system in children 7-13 years of age with type 1 diabetes","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0421","article-title":"Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes","volume":"19","author":"Garg","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2337\/dc18-1881","article-title":"Home use of day-and-night hybrid closed-loop insulin delivery in very young children: a multicenter, 3-week, randomized trial","volume":"42","author":"Tauschmann","year":"2019","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.23736\/s2724-5276.21.06531-9","article-title":"Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children","volume":"73","author":"Ferrito","year":"2021","journal-title":"Minerva Pediatr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1515\/sjph-2015-0021","article-title":"Type 1 diabetes in the young: Organization of two national centers in Israel and Slovenia","volume":"54","author":"Bratina","year":"2015","journal-title":"Zdr Varst."},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1525822X17749386","article-title":"Quantifying thematic saturation in qualitative data analysis","volume":"30","author":"Lowe","year":"2018","journal-title":"SAGE journals"},{"key":"B21","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0153","article-title":"Lived experience of advanced hybrid closed\u2013loop versus hybrid closed\u2013loop: Patient\u2013reported outcomes and perspectives","volume":"23","author":"Hood","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.3965","article-title":"Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes","volume":"175","author":"Abraham","year":"2021","journal-title":"JAMA Pediatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12872","article-title":"Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes","volume":"20","author":"Musolino","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816631568","article-title":"Hybrid closed\u2013loop insulin delivery in type 1 diabetes during supervised outpatient conditions","volume":"10","author":"Grosman","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2468","article-title":"Multinational home use of closed-loop control is safe and effective","volume":"39","author":"Anderson","year":"2016","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820985103","article-title":"Real-world efficacy of the hybrid closed-loop system","volume":"16","author":"Usoh","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2020.1784724","article-title":"Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy","volume":"17","author":"Fuchs","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2019.10.009","article-title":"Evolution of diabetes technology","volume":"49","author":"Dovc","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108986","article-title":"Amelioration of user experiences and glycaemic outcomes with an advanced hybrid closed loop system in a real-world clinical setting","volume":"178","author":"Beato-V\u00edbora","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30001-3","article-title":"Day\u2013and\u2013night glycaemic control with closed\u2013loop insulin delivery versus conventional insulin pump therapy in free\u2013living adults with well controlled type 1 diabetes: an open\u2013label, randomised, crossover study","volume":"5","author":"Bally","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13304","article-title":"Hypoglycemia incidence and recovery during home use of hybrid closed\u2013loop insulin delivery in adults with type 1","volume":"20","author":"Ruan","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13816","article-title":"Is an artificial pancreas (closed-loop system) for type 1 diabetes effective","volume":"36","author":"Boughton","year":"2019","journal-title":"Diabetes Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): A multicentre, randomised, crossover trial","volume":"16","author":"Bergenstal","year":"2021","journal-title":"Lancet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.967725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T10:26:21Z","timestamp":1660904781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.967725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":34,"alternative-id":["10.3389\/fendo.2022.967725"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.967725","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"967725"}}